Back
Speaker illustration

Doctor Krister Jarbrink

BioPharmaceuticals Medical, AstraZeneca, Gothenburg (Sweden)

Presentations

Cardiac manifestations as precursors to ATTR amyloidosis diagnosis: results from the multi-country OverTTuRe study

Event: Heart Failure 2024

Topic: Epidemiology, Prognosis, Outcome

Session: Amyloid cardiomyopathy: epidemiology, diagnosis, prognostic and treatment

Access
Like
Thumbnail

REVEAL-CKD: Prevalence of undiagnosed stage 3 chronic kidney disease in patients with heart failure in Canada

Event: Heart Failure 2023

Topic: Comorbidities

Session: Chronic heart failure - comorbidities

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources